121 related articles for article (PubMed ID: 34866362)
1. Computational detection of a genome instability-derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma.
Guo CR; Mao Y; Jiang F; Juan CX; Zhou GP; Li N
Cancer Med; 2022 Feb; 11(3):864-879. PubMed ID: 34866362
[TBL] [Abstract][Full Text] [Related]
2. Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma.
Zhang Y; Wang Y; He X; Yao R; Fan L; Zhao L; Lu B; Pang Z
BMC Cancer; 2023 May; 23(1):430. PubMed ID: 37173624
[TBL] [Abstract][Full Text] [Related]
3. Development of six immune-related lncRNA signature prognostic model for smoking-positive lung adenocarcinoma.
Zhou D; Wang J; Liu X
J Clin Lab Anal; 2022 Jun; 36(6):e24467. PubMed ID: 35561270
[TBL] [Abstract][Full Text] [Related]
4. The potential use and experimental validation of genomic instability-related lncRNA in pancreatic carcinoma.
Xia X; Zhao S; Song X; Zhang M; Zhu X; Li C; Chen W; Zhao D
Medicine (Baltimore); 2023 Sep; 102(37):e35300. PubMed ID: 37713870
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA signature for predicting gastric cancer survival based on genomic instability.
Zhang J; Chen L; Wei W; Mao F
Aging (Albany NY); 2023 Dec; 15(24):15114-15133. PubMed ID: 38127056
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA Signatures of Genome Instability to Predict Survival in Patients with Renal Cancer.
Huang L; Xie Y; Jiang S; Han W; Zeng F; Li D
J Healthc Eng; 2021; 2021():1090698. PubMed ID: 34917302
[TBL] [Abstract][Full Text] [Related]
7. A mutator-derived prognostic eRNA signature provides insight into the pathogenesis of breast cancer.
Wang R; Gou Y; Tang M; Wang K; He H; Yang J; Yang Y; Jing Y; Tang Q
Exp Cell Res; 2023 Oct; 431(1):113754. PubMed ID: 37611728
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an endoplasmic reticulum stress-associated lncRNA prognostic signature and the tumor-suppressive role of RP11-295G20.2 knockdown in lung adenocarcinoma.
Yu L; Zhou S; Hong W; Lin N; Wang Q; Liang P
Sci Rep; 2024 May; 14(1):12283. PubMed ID: 38811828
[TBL] [Abstract][Full Text] [Related]
9. Role of hippo pathway and cuproptosis-related genes in immune infiltration and prognosis of skin cutaneous melanoma.
Lv H; Liu L; He Y; Yang K; Fu Y; Bao Y
Front Pharmacol; 2024; 15():1344755. PubMed ID: 38515849
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma.
Zhong L; Chang W; Luo B; Gao W; He H; Fang M; Li H; Wen Z; Chen Y
Cancer Cell Int; 2024 Jan; 24(1):2. PubMed ID: 38167017
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village.
Ao YQ; Gao J; Jiang JH; Wang HK; Wang S; Ding JY
Mol Ther; 2023 Dec; 31(12):3389-3413. PubMed ID: 37740493
[TBL] [Abstract][Full Text] [Related]
12. Genome instability-derived genes as a novel prognostic signature for lung adenocarcinoma.
Zhang X; Lam TW; Ting HF
Front Cell Dev Biol; 2023; 11():1224069. PubMed ID: 37655157
[No Abstract] [Full Text] [Related]
13. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer.
Lai LT; Ren YH; Huai YJ; Liu Y; Liu Y; Wang SS; Mei JH
Front Genet; 2023; 14():1139994. PubMed ID: 37007961
[No Abstract] [Full Text] [Related]
15. The multi-omics analysis identifies a novel cuproptosis-anoikis-related gene signature in prognosis and immune infiltration characterization of lung adenocarcinoma.
Jiang G; Song C; Wang X; Xu Y; Li H; He Z; Cai Y; Zheng M; Mao W
Heliyon; 2023 Mar; 9(3):e14091. PubMed ID: 36967927
[TBL] [Abstract][Full Text] [Related]
16. Forkhead box L2 is a target of miR-133b and plays an important role in the pathogenesis of non-small cell lung cancer.
Li J; Gao L; Wang A; Qian H; Zhu J; Ji S; Chen J; Liu Z; Ji C
Cancer Med; 2023 Apr; 12(8):9826-9842. PubMed ID: 36846934
[TBL] [Abstract][Full Text] [Related]
17. A novel machine learning model based on ubiquitin-related gene pairs and clinical features to predict prognosis and treatment effect in colon adenocarcinoma.
Liang L; Liu L; Mai S; Chen Y
Eur J Med Res; 2023 Jan; 28(1):41. PubMed ID: 36681855
[TBL] [Abstract][Full Text] [Related]
18. m
Wu H; Xu H; Huang S; Tang Y; Tang J; Zhou H; Xie L; Qiao G
Front Oncol; 2022; 12():989817. PubMed ID: 36249006
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma.
Huang Q; Yang S; Yan H; Chen H; Wang Y; Wang Y
Front Genet; 2022; 13():907058. PubMed ID: 36246596
[No Abstract] [Full Text] [Related]
20. Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma.
Yang X; Wang X; Sun X; Xiao M; Fan L; Su Y; Xue L; Luo S; Hou S; Wang H
Front Genet; 2022; 13():972899. PubMed ID: 36160015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
